Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: Results from further analysis of the large international TARGIT-A trial led from University College London brings more good news for patients diagnosed with breast cancer. Four important questions have been answered by this new analysis.
May 27, 2021
TARGIT-IORT is a pioneering breast cancer therapy developed by UCL clinicians, which requires just one shot of radiotherapy. With TARGIT-IORT therapy, eight out of every ten patients have no need for any further post-operative radiotherapy treatments.
Barriers for Underserved Black Women
TARGIT Collaborative Group Advocates Wider Adoption of TARGIT-IORT to Address Racial
Disparities and Reduce Compliance Issues
February 18, 2021
SACRAMENTO, Calif., (GLOBE NEWSWIRE) — Black women experience longer
breast cancer treatment times and may have less access to essential radiation technology,
according to a recent study published in the journal Cancer. 1 In response, the TARGIT
Collaborative Group (TCG), a national cancer advocacy organization of doctors and scientists
working to improve cancer patient care, endorses single-dose radiation as a potential solution
to address barriers to care that disproportionately affect black women with early-stage breast
cancer in the United States.
View the full article HERE
Posted January 29, 2021
WLBT-3 TV On Your Side – Jackson, Mississippi
Less intense breast cancer radiation treatment, practiced in Europe for two decades, is now available here in Mississippi.
View the full article HERE
Posted January 27, 2021
Madison County Journal – Madison County, Mississippi
Merit Health Women’s Hospital is the first hospital in Mississippi to offer single-dose intraoperative radiotherapy for qualifying early-stage breast cancer patients.
View the full article HERE
Miss. hospital offers single-dose radiation therapy for breast cancer patients
Posted January 22, 2021
WLBT-3 TV On Your Side – Jackson, Mississippi
Merit Health Woman’s Hospital in Flowood is offering a new treatment of single-dose radiation therapy for qualifying early-stage breast cancer patients.
Posted January 22, 2021
Winston County Journal; Pelahatchie News; SW Rankin News – Mississippi
One-time treatment can eliminate up to six weeks of radiotherapy while reducing exposure to COVID-19.
View the full article HERE
Delaying cancer treatment amid COVID is creating a secondary public health crisis
Posted January 17, 2021
Rome Sentinel – Rome, New York
COVID-19 has inadvertently caused substantial increases in the number of avoidable cancer deaths as a result of diagnostic and treatment delays.
How Good Shepherd treats breast cancer with just one dose of radiation
Posted December 30, 2020
Daily Herald – Arlington Heights, IL
Typically breast cancer patients go through several weeks of radiation.
Single-dose radiation therapy may lessen, eliminate unsafe additional outside trips during the pandemic
Posted December 14, 2020
News Medical Life Sciences – Manchester, UK
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.
TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 3- to 6-week radiotherapy, significantly reducing COVID-19 risk to patients amidst coming surge
Posted December 2, 2020
SACRAMENTO, Calif., (GLOBE NEWSWIRE) — The TARGIT Collaborative Group announced today that according to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of seeking treatment or completing their many week course of post-lumpectomy radiotherapy.
Five Important Advances in Breast Cancer Treatment
Posted November 20, 2020
Managed Healthcare Executive – MHE Publication, MHE November 2020, Volume 30, Issue 11
Two newly approved antibody-drug conjugates and changes in radiation therapy lead the way.
Although there isn’t a cure for breast cancer, more effective treatments continue to emerge. Here’s a look at five developments for breast cancer treatment in the last two years.